P. Pimsa, “Progression Free Survival with Erlotinib in First Line Treatment EGFR Mutated Non-Small Cell Lung Cancer Stage IV in Sunpasitthiprasong Hospital”, J Health Sci BCNSP, vol. 10, no. 1, p. e287170 , Apr. 2026.